Baby ABS (Abdominal Binder Study)
Recruiting
N/A
Interventional Study
Premature
Premature Lungs
Ventilator Lung; Newborn
Rectus Abdominis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 26 Weeks – 31 Weeks
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 40 (estimated)
- Sponsor
- University of Minnesota · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The primary outcome of this study is to determine if the use of the FDA-approved DandleLion NeoBellyBand increases the thickness of the rectus abdominis muscle in premature babies receiving continuous positive pressure ventilation, leading to infants reaching full oral feedings at an earlier corrected gestational age.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Premature viable neonates with corrected gestational age of 26-31 weeks
* Anticipated to require non-invasive continuous positive pressure ventilation including bCPAP, CPAP, and NAVA CPAP for a minimum of 2 weeks either on their first trial of CPAP or after extubation.
Exclus…
Contacts